Search results
Results from the WOW.Com Content Network
However, mAbs are large molecules and due to the blood–brain barrier, uptake of mAb into the brain is extremely limited, only approximately 1 of 1000 mAb molecules is estimated to pass. [25] However, the Peripheral Sink hypothesis proposes a mechanism where mAbs may not need to cross the blood–brain barrier. [26]
A monoclonal antibody (mAb, more rarely called moAb) is an antibody produced from a cell lineage made by cloning a unique white blood cell. All subsequent antibodies derived this way trace back to a unique parent cell.
The MAB II was created by psychologist Douglas N. Jackson and published by the company SIGMA Assessment Systems Inc. It is designed to measure intellectual abilities of both adults and adolescents from ages 16 and over and can be used in any educational and career counselling settings, business, industries, clinics and mental health facilities for basic research.
mAbs is a peer-reviewed multi-disciplinary scientific journal established in 2009, published by Taylor & Francis and dedicated to the art and science of antibody research and development.
At IDEC, Rastetter was a co-inventor of and developed Rituxan, the first monoclonal antibody (MAB) to be approved by the U.S. FDA for cancer therapy. [14] [15] In 2003, Idec merged with Biogen to form the third largest biotech firm in the United States. Rastetter was Executive Chair of the new company, Biogen IDEC, from 2003 to 2005. [4] [16]
MAB Corporation, an Australian property company; MAB Paints, an American company 1899–2007; Malaysia Airlines (Malaysia Airlines Berhad, MAB) Malicet et Blin (M.A.B.), French bicycle and automobile manufacturer 1890–1925; Manufacture d'armes de Bayonne, a French pistol manufacturer; Mercado Alternativo Bursátil, Spain's alternative stock ...
Etizolam tablets manufactured by Intas.. The company was founded by a Jain pharmacist Hasmukh Chudgar in 1977 [5] and was incorporated in 1985. [6]In 2013, ChrysCapital acquired 16.14% stake in the company, and in 2015, ChrysCapital subsequently sold 10.13% to Singapore-based Temasek Holdings [7] and in 2017, it further diluted 3.01% stake to Capital International.
Mabelle Massey Segrest, known as Mab Segrest (born February 20, 1949), is an American lesbian feminist, writer, scholar and activist associated with the American South. Segrest is best known for her 1994 autobiographical work Memoir of a Race Traitor, which won the Editor's Choice Lambda Literary Award .